Insights provides context and perspective about key pharmacy trends and issues

Female caregiver and elderly patient discussing medical information on a couch
Specialty
Research published by Coram shows that helping patients transition to at-home or ambulatory center infusion treatments can be beneficial to both patients and payors. More
Briefing
Icon of an infusion bag, overlaying a rising line graph
Specialty
Multiple Sclerosis is a $19 billion market worldwide, and the third most expensive specialty drug spend category. Recently approved Ocrevus is likely to add to cost of treatment and needs... More
Briefing
Care Management
Why Women Should Quit Smoking More
Briefing
Drug Pipeline
What's Next for Hemophilia Therapy and New Treatment Options? More
Briefing
Public Policy
RSV Surge Raises Concern About Winter Virus Crisis More
Briefing
Specialty
A Virtual Approach to Keep Specialty Costs Down More
Briefing
Cost Management
Predicting and Preventing Hospitalizations During Radiation Treatment More
Briefing
Drug Pipeline
New Drugs for Ophthalmic Disorders on the Horizon More
Briefing
Care Management
Everything You Need to Know about Vaccine Protection Against the Flu & COVID-19 More
Commentary
Care Management
Women’s Health Is Good Business More
Briefing